Claims
- 1. A method in a computer system for preventing atypical clinical events related to information identified by DNA testing a person, comprising the steps of:
receiving clinical agent information, the clinical agent information including an identifier of the agent; determining if a gene is associated with the clinical agent information, and inquiring if the person has a genetic test result value for the gene, and if not, generating an output including information regarding the likelihood that the person has a gene variant indicative of an atypical event.
- 2. The method of claim 1, wherein the step of generating the output includes determining if hereditary information for the person is available, and if so, determining if the hereditary information indicates a variation from the risks of the presence of a polymorphism in the general population.
- 3. The method of claim 2, wherein the hereditary information includes information selected from one of the groups consisting of gender, race, ethnicity and geographic distribution.
- 4. The method of claim 2, further comprising the step of obtaining hereditary information relating to the person.
- 5. The method of claim 4, wherein the hereditary information is obtained from an electronic medical record of the person stored within a comprehensive healthcare system.
- 6. The method of claim 2, further comprising the step of initiating a clinical action if a test result value is not available for the person and the information regarding the risks indicates a significant risk that the person carries a gene variant associated with an atypical event.
- 7. The method of claim 6, wherein the clinical action is ordering a genetic test.
- 8. A computer system for preventing atypical clinical events related to information identified by DNA testing a person, comprising:
a receiving component that receives clinical agent information, the clinical agent information including an identifier of the agent; a determining component that determines if a gene is associated with the clinical agent information; an inquiring component that inquires if the person has a genetic test result value for the associated gene, and a generating component that generates an output including information regarding the likelihood that the person has a gene variant indicative of an atypical event.
- 9. The computer system of claim 8, wherein the generating component includes a first determining component and a second determining component, wherein the first determining component determines if hereditary information for the person is available and wherein the second determining component determines if the hereditary information indicates a variation from the risks of the presence of a polymorphism in the general population if the first determining component determines that no hereditary information is available.
- 10. The computer system of claim 9, wherein the hereditary information includes information selected from one of the groups consisting of gender, race, ethnicity and geographic distribution.
- 11. The computer system of claim 9, further comprising an obtaining component that obtains hereditary information relating to the person.
- 12. The computer system of claim 11, wherein the hereditary information is obtained from an electronic medical record of the person stored within a comprehensive healthcare system.
- 13. The computer system of claim 9, further comprising an initiating component that initiates a clinical action if a test result value is not available for the person and the information regarding the risks indicates a significant risk that the person carries a gene variant associated with an atypical event.
- 14. The computer system of claim 13, wherein the clinical action is ordering a genetic test.
- 15. A computer-readable medium containing instructions for controlling a computer system for preventing atypical clinical events related to information identified by DNA testing a person, comprising the steps of:
receiving clinical agent information, the clinical agent information including an identifier of the agent; determining if a gene is associated with the clinical agent information, and inquiring if the person has a genetic test result value for the gene, and if not, generating an output including information regarding the likelihood that the person has a gene variant indicative of an atypical event.
- 16. The computer-readable medium of claim 15, wherein the step of generating the output includes determining if hereditary information for the person is available, and if so, determining if the hereditary information indicates a variation from the risks of the presence of a polymorphism in the general population.
- 17. The computer-readable medium of claim 16, wherein the hereditary information includes information selected from one of the groups consisting of gender, race, ethnicity and geographic distribution.
- 18. The computer-readable medium of claim 16, further comprising the step of obtaining hereditary information relating to the person.
- 19. The computer-readable medium of claim 18, wherein the hereditary information is obtained from an electronic medical record of the person stored within a comprehensive healthcare system.
- 20. The computer-readable medium of claim 16, further comprising the step of initiating a clinical action if a test result value is not available for the person and the information regarding the risks indicates a significant risk that the person carries a gene variant associated with an atypical event.
- 21. The computer-readable medium of claim 20, wherein the clinical action is ordering a genetic test.
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of priority to U.S. patent application Ser. No. 09/981,248, filed Oct. 16, 2001, which claims the benefit of priority to U.S. Provisional Application No. 60/285,263, filed Apr. 20, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60285263 |
Apr 2001 |
US |
Divisions (1)
|
Number |
Date |
Country |
Parent |
09981248 |
Oct 2001 |
US |
Child |
10826563 |
Apr 2004 |
US |